SCHEMBL13616780

SCHEMBL13616780

C=C(C)C(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14886369 0.77
SCHEMBL800179 0.73
SCHEMBL15759387 0.73 TDP1 (0.44)
SCHEMBL16140641 0.73 ALDH1A1 (0.45)
SCHEMBL180158 0.71
SCHEMBL1895993 0.71
SCHEMBL1716302 0.71
Ammonia Solution, Strong SCHEMBL16053162 0.71 TSHR (0.39)
SCHEMBL6914033 0.71
SCHEMBL134267 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106397682-A Preparation method of slump loss resistant polycarboxylate water reducer 江苏中铁奥莱特新材料股份有限公司 2017-02-15 CN claimed
EP-2113500-A1 MAPK/ERK kinase inhibitors Takeda Pharmaceutical Company Limited (JP) 2009-11-04 EP disclosed
US-7576122-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2009-08-18 US disclosed